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Gallbladder cancer is a common malignancy of the
biliary tract. It is the fifth common malignancy of the
gastrointestinal tract in United States [1] and third in
Northern India [2]. Despite such high prevalence,
there is scanty published literature about this disease
in indexed journals. Therefore, this article is intended
to provide a brief overview of gallbladder cancer risk
factors, based mainly on published evidence from
analytical epidemiology and recent research findings
of biologists and practising oncologists. Furthermore,
an attempt has been made to establish an association
between different causative factors and the occur-
rence of the disease.
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PATHOLOGY
Gallbladder cancer is usually present as a
localized extensive tumor. The whole gallbladder
may appear thickened, lobulated, and contracted
into the liver. Occasionally it may be filled with
purulent material mucus or stones which may
cause extensive hemorrhage and necrosis and
sometimes even lead to perforation. Carcinoma is
most often located in the fundus and may be
present as a mucosal plaque, a polypoid or papil-
lary excrescence or discrete thickening of wall,
sometimes with an attached gallstone [3- 5].
Gallbladder cancer has several histopathologi-
cal features. In the majority of cases, it is an adeno-
carcinoma (85-90%) which can be papillary,
nodular, tubular or a combination with varying
degrees of invasions. The histopathological grade
and degree of metaplasia have prognostic sig-
nificance, whereas other histopathological types
are undifferentiated or anaplastic carcinoma (2-
7%), pure squamous cell carcinoma (1-6%) and
adenosquamous carcinoma (1-4%) [6,7]. Rare
types of gallbladder cancer include malignant
melanomas, lymphomas, sarcomas and carcinoid
tumors. Fahim [8] explained different modes of
spread of gallbladder cancer including direct,
lymphatic, vascular, neural, intraperitoneal and
intraductal. Nodular tumors are more likely to
infiltrate early, invade the liver and spread to
adjacent lymph nodes than papillary tumors.
At an advanced stage, the gallbladder is
unresectable in most patients. It is difficult to
diagnose malignancy at an early stage due to its
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nonspecific symptoms. However, recent ad-
vances in preoperative imaging of early gall-
bladder malignancy and its radical aggressive
surgery leads to improvement in survival [9].
GEOGRAPHICAL DISTRIBUTION
Gallbladder cancer is a relatively rare neoplasia in
the world and its incidence shows considerable
geographical variation. The complete ascertain-
ment of all previously diagnosed cases of gall-
bladder cancer in a defined area is a difficult task.
However, such data have been collected from
specific areas in different time period. In a popu-
lation-based case-control study of cancer of bile
ducts and gallbladder in Greater Montreal be-
tween 1984 and 1988, a total of 24 patients with
cancer of bile ducts and 33 patients with cancer of
gallbladder were compared to 239 population-
based controls. Gallbladder cancer riskwas found
to be eight times more in those having previous
gallbladder problem than controls [10].
The Surveillance, Epidemiology and End Re-
sults (SEER) program ofNational Cancer Institute
(NCI) of United States provides data indicating
racial and ethnic variations in the incidence of
gallbladder cancer in United States. The average
annual age-adjusted incidence rates between
1975-1985 per 100,000 for selected gallbladder
cancer cases varied with sex between racial and
ethnic groups. The incidence rate among males
was 0.8 White, 0.8 Black, 1.5 Hispanics, 8.9
American Indians, 1.2 Chinese, 1.5 Japanese,
1.2 Filipinos and 1.4 Hawaiians, whereas among
females it was 1.6 White, 1.1 Black, 7.1 Hispanics,
17.1 American Indians, 1.0 Chinese, 1.7 Japanese,
1.8 Filipinos and 1.3 Hawaiians. In United
States, the incidence is highest in New Mexico
accounting 8.3% of all cancers. In Israel, a very
high rate of gallbladder cancer includes 13.8 per
100,000 females and 7.5 per 100,000 males. Similar
to United States, wide variations in incidence
rates exist throughout the world [11]. The
incidence rate also varies within the Indian
population. It is very high in Northern India, 4.5
per 100,000 for males and 10.1 per 100,000 for
females, butlow in South India, 1.2 per 100,000 for
males and 0.9 per 100,000 for females as reported
by the population-based cancer registry, Delhi
[12]. Other countries with high rates of gallblad-
der cancer include Bolivia, Chile and Northern
Japan. Such variation in incidence rate is influ-
enced by genetic, environmental, diet and socio-
economic factors 11].
Moreover, migration from native land also
affects the incidence rate of gallbladder cancer.
Swerdlow [13] compared the risk of cancer
mortality (during 1973 to 1985) in persons who
were born in Indian subcontinent but migrated to
England and Wales, with the ethnic population of
the country, for various kinds of cancer. There
was a substantial increased risk of gallbladder
cancer in females of Indian ethnicity than other
British ethnic migrants.
Descriptive epidemiology is used to investigate
the occurrence of gallbladder cancer in different
population groups. The incidence rate of gall-
bladder cancer can be derived only from popula-
tion-based cancer registries. However, the
number of such registries in the world has in-
creased steadily over the last 50 years, but in
comparison with the availability of data on
mortality, the population so covered remains
limited. Furthermore, the populations served by
cancer registries often comprise only the inhab-
itants of a major city and do not represent the
country as a whole.
AGE
In general, the incidence of gallbladder cancer
rises with advancing age. The enhanced suscep-
tibility to cancer may result from the impairment
of gene and immune functions associated with
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Paraskevopoulos [14] reported that gallbladder
cancer incidence rate increases progressively
with age, particularly after the fifth decade.
Sipetic [15] analysed the epidemiological situa-
tion of chosen malignant tumors of digestive tract
for the period 1960-1990 in Serbia. Based on
mortality rate, it was reported that more women
died of gallbladder cancer than men (1.8:1). In
both male and female population, the highest
average specific mortality rate was observed for a
person over the age of 75 years.
SEX
As evident from medical reports, the prevalence
of gallbladder cancer is higher in females than
males. According to SEER program of NCI of
United States, the incidence of gallbladder per
100,000 is higher among white females than males
between 1981 1985. The incidence and mortality
rates for primary gallbladder cancer in white
males and females were 1.6 and 1.1, respectively
[11]. About 75% of female patients are in their
seventies and their diagnosis is made during
surgical exploration. In more than three-fourth
patients, gallbladder cancer is associated with
cholelithiasis [1,16-18].
A retrospective study of 14,018 malignant
tumors from Northern Pakistan reflects differen-
tial pattern of cancer distribution among different
ethnic groups like Pathans, Punjabis and others.
When the standardized cancer ratio (ASCAR) was
calculated to compare the data from the neigh-
bouring countries of the region, higher frequency
was found for the prostate cancer in males and
gallbladder carcinoma in females [19].
Rougereau and co-workers [20] recorded 77
cases of primary gallbladder carcinoma in Calva-
dos Digestive Tumors Registry covering a popu-
lation of 589,559 inhabitants between 1978-1986.
The crude incidence was 2.4/100,000 in females
and 0.6/100,000 in males (sex ratio 3.8). Similarly,
56 patients with carcinoma of gallbladder were
treated during the year 1969-1987 at the Beth
Israel Medical Centre, New York, USA. The
disease was found to be most common among
elderly females with cholelithiasis [21].
SEX HORMONES
The preponderance of gallstones in women [20]
suggests that female sex hormones play a role in
the pathogenesis of gallstones which are present
in a majority of cases of gallbladder cancer [211.
Chen and Huminer [22] found high level of
estrogen and its receptor (ER) in gallbladder
cancer. Nakamura and co-workers [23] carried
out immuno-histochemical examination of can-
cerous tissues from 21 patients with primary
gallbladder cancer and observed nuclear localiza-
tion of ER in 52.4% patients. However, moder-
ately and poorly differentiated adenocarcinoma
have a relatively higher tendency of ER-positivity
than well differentiated adenocarcinoma. The ER
associated protein p29 and estrogen induced
protein pS2 were expressed in cancer gallbladder
tissues [23]. Earlytumors had a significantlylower
expression of p29 than advanced tumors and me-
tastases [24]. Furthermore, the relationship be-
tween combined oral contraceptive and primary
gallbladder cancer was examined in 58 cases and
355 controls participating in an international
hospital based case-control study. Use of com-
bined oral contraceptive at any time was not
associated with the risk of developing gallbladder
cancer. There was also no evidence that the oral
contraceptives caused risk of gallbladder cancer
in women with or without a prior history of
gallbladder disease. A history of gallbladder dis-
ease or gallstones was a strong risk factor for
gallbladder cancer [25]. Epidemiological studies
also show a strong association between gallblad-
der cancer, obesity and estrogen [26, 27].
Recently Lichtman [25] examined pre-meno-
pausal and post-menopausal females into their
fifth decade and found gallbladder disease and
breast cancer as the possible side effects of hor-
mone replacement therapy.220 P. CHAURASIA et al.
GENETIC FACTORS
Multistep models of carcinogenesis require a
series of genetic and epigenetic events to occur
during both the initiation and progression of
malignancy. While the precise nature of all steps
leading to malignancy remains unknown, vari-
ous oncogenes and tumor suppressor genes are
sequentially altered either through mutations or
deletions [28,29]. Kamel and co-workers [30]
found that mutations in p53 and c-erbB-2 play a
major role in neoplastic transformation of
gallbladder epithelial cells. Co-expression of p53
and c-erbB-2 suggests that alterations of these
genes might act in concert during the neoplastic
transformations. The expression of p53 in gall-
bladder dysplasia suggests that p53 mutation
could be an early event in the evolution of some
gallbladder carcinomas. The study of Wee et al.
[31] also supported the notion that p53 mutation
may have a role in the pathogenesis of gall-
bladder cancer. Similarly, Yabar and Yatanabe
[32] reported overexpression of p53 gene and
protein in adenocarcinoma of gallbladder with a
typical epithelium. Current histopathological
evidence suggests that two distinct pathways
are involved in gallbladder carcinogenesis: (1) de
novo carcinoma develops from a predominant
p53 alteration with low K-ras mutation, and (2)
carcinoma in pyloric gland type adenoma deve-
lops from alteration in p53, K-ras and APC genes
[33].
Wistuba et al. [34] investigated the incidence of
ras gene mutations and loss of heterozygosity
(LOH) at p53, DCC and Rb genes and 5q, 3p, 8p
and 9p loci from 25 gallbladder carcinomas in
Chile. LOH of p53 occurred more frequently and
earlier than protein overexpression. Todoroki
and co-workers [35] detected point mutations in
p16InK4/CDKN2 gene (a regulatory gene of
mammalian cell cycle) resulting in primary
carcinoma of biliary tract. This includes 15 mis-
sense and 2 silent mutations. The frequency of
mutations in gallbladder cancer and hilar bile
duct cancer were 80% (8 of 10) and 63% (5 of 8),
respectively. Recently, a src-related signal path-
way represented the role of activated ras and src
oncogene products in the acquisition of fully
neoplastic phenotype by human gallbladder
adenocarcinoma cells [36]. The expression of c-
fos protein plays an important role in the develop-
ment of gallbladder neoplasia with increased
immunoreactivity in gallbladder cancerbut not in
chronic cholecystitis, biliary tract and ampullary
neoplasms [37]. Oncogenic K-ras codon 12 muta-
tion was detected in 59% (30 of 51) of gallbladder
carcinomas, 73% (8 of 11) of gallbladder dysplasia
and in gallstones. This is an important precancer-
ous lesion of gallbladder carcinogenesis [38].
Sasatomi et al. [39] found an increased frequency
of apoptosis with the progression of gallbladder
carcinoma. Oncogenic alterations of bcl-2 and p53
may also play a role in tumorigenesis of gall-
bladder carcinoma, but these changes had no
correlation with spontaneous apoptosis [39].
CHOLELITHIASIS
A history of gallbladder disease or gallstones is
a strong risk factor for gallbladder cancer. In
ultrasound findings, 4 out of 5 cases of primary
carcinoma of the gallbladder had associated
gallstones [40]. Gallstones or a previous chole-
cystectomy for gallstones was reported in 44% of
women and 23% of men in a postmortem exami-
nation of patients in the Canton of Thrgau be-
tween 1989-1991. Among the gallstones carriers,
8% of women and 2.5% of men had developed a
gallbladder carcinoma [41]. An interracial study
has been carried out with respect to gallstone size,
growth and the relation between stone size and
gallbladder cancer. The prevalence of gallstones
differs markedly among 1676 females (169 White,
531 Black and 976 American Indians). One-third
of all gallbladder cancers in subjects with calculi
was associated with large stones [42]. Thus the
stone size might be used to determine the risk of
gallbladder cancer in patients with gallstones.
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percent of patients undergoing cholecystectomy
for gallstones in some studies [1, 43, 44].
Bllesta-Vicente and co-workers [45] reviewed
retrospectively 120 patients with histologically
diagnosed gallbladder carcinoma during a period
of 16 years (1974-1989). The results showed that
(i) the annual incidence of gallbladder carcinoma
remains unchanged; (ii) there is a close associa-
tion ofcancerwith gallstone; (iii) the late diagnosis
is due to non-specificity of clinical manifestations
and (iv) early gallbladder carcinoma is only
diagnosed by chance in cholecystectomy.speci-
mens. Calvados Digestive Tumour Registry re-
corded 77 primary gallbladder carcinomas out of
125 extra-hepatic bile duct carcinomas between
1978 and 1986 [20]. However, out of 74 operated
patients gallbladder carcinoma was diagnosed
preoperatively in only 13.5%, cholelithiasis was
found to be associated with 81.3%.
Nadler and McSherry [21] reviewed 56 patients
with carcinoma of gallbladder treated during the
17-year period 1969-1987 at the Beth Israel
Medical Centre, New York, and found cholelithi-
asis as the major causative agent of gallbladder
carcinoma among elderly women.
CHOLECYSTECTOMY
The risk of malignancy associated with calcified
or porcelain gallbladder is about 20% [46]. Zhou
[47] demonstrated post operative recurrence of
gallbladder carcinoma. The study was divided
into two groups namely A and B. Group A (48
cases) represents patients dying within one year
of operation and Group B (23 cases) represents
those who remain alive for more than three
years. Clinico-pathological, morphological and
histological examinations showed statistically
significant differences between the two groups.
Risk factors relating to early post-operative
recurrence of gallbladder carcinoma included
many factors like, deeply involved liver par-
enchyma (> 75mm in depth), cervical cancer and
palliative resection.
ABO BLOOD GROUPS
A high incidence of various cancers like gastric,
salivary, colon, pancreas, kidney, bladder, uterus,
ovary and cervix in blood group A has been well
documented.
Juvonen and Niemela [48] analysedABOblood
group in 171 patients with symptomatic gall-
stones. However, they could not draw any signi-
ficant correlation between formation of gallstones
and different blood groups except blood groupA
who had multiple stones.
Similarly in a mirror image paper, Pandey et al.
[49] studied the distribution ofABO and Rhblood
groups in 69 patients with gallbladder cancer and
152 patients with cholelithiasis registered at the
Banaras Hindu University hospital. Like other
carcinomas, an increased frequency of gallblad-
der carcinoma was found in blood groups A and
AB when compared with the control population.
This appears to be due to higher formation of
gallstones in blood group A population. An
increased risk of development of gallbladder
cancer in patients with blood group A has been
attributed to the expression ofForssmann antigen
in these patients. Forssmann antigen has structur-
al similarity with blood group antigenA [49].
Thus antibodies to blood group A probably
attach precancerous and cancerous cells expres-
sing Forssmann antigen. Blood group A and AB
lack antibodies to A and hence are theoretically
more susceptible to develop these carcinomas.
CARCINOGENS
As in other carcinomas, the role of carcinogens
in the involvement of gallbladder cancer cannot
be ruled out. It has been reported that methyl-
cholanthrene, O-aminoazotoluene and nitrosa-
mines cause gallbladder cancer in hamsters [50].
It is likely that adulteration of mustard oil with
some carcinogen acts as an aetiological factor for
high incidence of gallbladder cancer in North
India [46]. Increased prevalence of gallbladder222 P. CHAURASIA et al.
cancer has also been related to specific occupa-
tions. For example, Paraf et al. [51] reported the
case of a 64-year old woman having squamous
cell carcinoma of the gallbladder with hepatic
metastases due to exposure to trichloroethylene
in a degreasing metal laboratory, although tri-
chloroethylene could not be assumed as a true
carcinogen for gallbladder cancer. A high in-
cidence of gallbladder cancer hasbeen reported in
individuals working in the rubber industry and
animal studies suggest that azotoluene and
nitrosamines are potent chemical carcinogens [1].
MISCELLANEOUS FACTORS
1. Anomalous Pancreatic Biliary
Duct Junction (APBDJ)
APBDJ allows reflux of pancreatic juice into
gallbladder leading to precancerous changes in
gallbladder mucosa [52]. Kimura et al. [53] re-
ported APBDJ in 17% patients of gallbladder
cancer but in only 3% of other hepatobiliary dis-
orders. Patients with choledochal cysts are more
prone to develop gallbladder carcinomas.
2. Typhoid Infection
Salmonella typhi infection has been found to be
associated with an increased risk of gallbladder
cancer and bile duct cancers [1,54]. There exists
no such correlation in Indian subcontinent where
typhoid infection is a common occurrence.
3. Rare Lesions
Mirizzi syndrome is a rare complication of long-
standing cholelithiasis. An elevated level of
tumor associated antigen CA 19-9 are indicative
of a coincidental gallbladder carcinoma [55].
Segmental adenomyomatosis of gallbladder,
chronic inflammatory bowel disease [56] and
polyposis coli [57] are rare associations with
gallbladder cancer.
CONCLUSION
Although abundant data concerning clinical
manifestation of gallbladder cancer have accu-
mulated, the genetic features of neoplasm still
remain ill-defined. In addition to genetic factors,
research based on several risk factors should be
undertaken to resolve issues relating to geogra-
phical variation, incidence rate, food habit, opti-
mal surgical and multidisciplinary management
of gall bladder cancer.
However, the possibility for preventing mor-
tality from this disease through early detection of
genetic markers may be possible in the future.
Recent advances in molecular biology will help in
understanding the mechanisms responsible for
development of biological heterogeneity in gall-
bladder cancer, the pathogenesis of invasion and
metastasis, and ultimately improved manage-
ment of the disease and perhaps its prevention.
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